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Abstract
Background:  The Wnt signal transduction pathway is important in a wide variety of
developmental processes as well as in the genesis of human cancer. Vertebrate Wnt pathways can
be functionally separated into two classes, the canonical Wnt/beta-catenin pathway and the non-
canonical Wnt/Ca2+ pathway. Supporting differences in Wnt signaling, gain of function of Wnt-1 in
C57mg mouse mammary epithelial cells leads to their morphological transformation while loss of
function of Wnt-5a leads to the same transformation. Many downstream target genes of the Wnt/
beta-catenin pathway have been identified. In contrast, little is known about the Wnt/Ca2+ pathway
and whether it regulates gene expression.
Results: To test the hypothesis that a specific cell line can respond to distinct Wnts with different
patterns of gene expression, we over-expressed Wnt-5a and Rfz-2 in C57mg mammary epithelial
cells and compared this cell line to C57mg cells over-expressing Wnt-1. These Wnts were chosen
since previous studies suggest that C57mg cells respond differently to these Wnts, and since these
Wnts can activate different signaling pathways in other systems. Using DNA microarray analysis,
we identified several genes that are regulated by Wnt-5a and Rfz-2 as well as by Wnt-1. We then
focused on two genes previously linked to various cancers, mesothelin and stromelysin-1, which
are respectively up-regulated by Wnt-1 and Wnt-5a in C57mg cells.
Conclusion: Different Wnts have distinct effects on gene expression in a single cell line.
Background
Wnt ligands are secreted glycoproteins that function in in-
tracellular signaling pathways to regulate a variety of de-
velopmental processes including cell growth, cell
differentiation, cell polarity, and apoptosis. Mis-regula-
tion of Wnt signaling leads to the development of several
human cancers, including colon carcinomas and melano-
ma [1]. Canonical Wnt signaling initiates in the binding
of a Wnt ligand to its cell surface receptor, members of the
frizzled gene family, along with the co-receptor LRP5/6
[2,3], leading to changes in the activities of cytoplasmic ef-
fectors resulting in the stabilization of beta-catenin pro-
tein. Beta-catenin then accumulates in the nucleus where
it interacts with its transcriptional co-activators, members
of the Lymphoid Enhancer Factor/T Cell Factor (LEF/TCF)
family of high mobility group DNA binding proteins to
regulate gene expression [1]. Many downstream gene tar-
gets of the canonical Wnt/beta-catenin pathway have been
identified http://www.stke.org.
There is a large family of Wnt ligands and not all Wnts are
thought to function in the same pathway. Wnts can be
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operationally separated into two classes; the first being a
class that transforms C57mg mouse mammary epithelial
cells and also promotes duplication of the dorso-ventral
axis when over-expressed in Xenopus embryos. Wnts in
this functional class activate the canonical Wnt/beta-cat-
enin pathway (Wnt-1, -3A, and -8). The second functional
group of Wnts does not transform C57mg cells nor pro-
mote axis duplication. Instead, when over-expressed in
frog or fish embryos, these Wnts perturb the movements
of gastrulation. Wnts in this class have been shown to sig-
nal in a non-canonical Wnt signaling pathway, the Wnt/
Ca2+ pathway (Wnt-5a, -4, -11). The Wnt/Ca2+ pathway
has been shown to increase intracellular Ca2+ levels in ze-
brafish embryos [4] and to activate PKC and CamKII in
Xenopus embryos [5,6] as well as in human melanomas
[7]. Moreover, it may activate Cdc42 [8] and JNK [9]. It is
important to emphasize that whether Wnts activate dis-
tinct responses and likely pathways is context-dependent,
and thus in other contexts a given Wnt may activate an-
other pathway.
Vertebrate Wnts signal through frizzled receptors that in
some experimental contexts (e.g., without co-expressing
LRP5/6) preferentially activate the Wnt/beta-catenin or
Wnt/Ca2+ pathways [5]. Interestingly, Wnt-5a may couple
to either pathway depending on which frizzled receptor is
present. When co-expressed with human frizzled-5, Wnt-
5a can induce a secondary axis in Xenopus [10]. In other
assays, however, Wnt-5a along with rat frizzled 2 (Rfz-2)
increases intracellular Ca2+ levels and activates PKC and
CamKII [4–6]. The activation of Wnt/Ca2+ signaling by
Wnt-5a and Rfz-2 seems to be antagonistic to the canoni-
cal Wnt signaling pathway. Specifically, Wnt-5a expres-
sion inhibits ectopic Wnt-8 induction of secondary axis
formation in Xenopus embryos [11]. Supportingly, the
endogenous expression of Wnt-5a maintains C57mg cells
in a normal growth state since anti-sense Wnt-5a mimics
Wnt-1 transformation of C57mg cells [12]. This data sug-
gests that Wnt-1 and Wnt-5a work in an opposing manner
in some cellular contexts. This potential role of Wnt-5a as
a tumor suppressor is further supported by the evidence
that ectopic Wnt-5a in human uroepithelial cells prevents
tumorigenesis when injected into athymic nude mice
[13].
Much is still unknown about how Wnt-5a signals and, im-
portantly, whether it regulates any genes. The ability of
dnWnt-11 to block expression of some genes in Xenopus
[6] and the ability of Wnt-5a to activate the Ca2+ sensitive
transcription factor nuclear factor of activated T cells
(NFAT) [14], support the likelihood that Wnt-5a can reg-
ulate gene expression through a beta-catenin-independ-
ent mechanism. We sought to identify genes regulated by
Wnt-5a and compare whether these were different from
canonical Wnt-1 gene targets using DNA microarray
analysis.
Results
To identify downstream genes regulated by Wnt-5a we
created C57mg cells that stably express both Wnt-5a and
Rfz-2, a potential ligand and receptor pair that in some as-
says function in the same signaling pathway. We overex-
pressed Rfz-2 in addition to Wnt-5a in C57mg cells in
order to augment the activation of noncanonical Wnt sig-
naling. Both have been shown to elevate intracellular
Ca2+ levels and to activate PKC and CamKII [4–6]. In ad-
dition Wnt-5a and Rfz-2 have been shown to synergize in
their induction of CamKII [6]. Wnt-1/C57mg cells were
also used for comparison, in an effort to identify genes
preferentially regulated by Wnt-5a. C57mg cells appeared
to respond to ectopic expression of both Wnt-5a and Rfz-
2 in C57mg cells since the cells exhibited a moderate re-
duction in growth rate in comparison to wildtype (wt)
C57mg cells as well as Wnt-1/C57mg cells (data not
shown). Phenotypically the Wnt-5a/Rfz-2/C57mg cells
were more spread out and the overall size of the cells in-
creased compared to wt C57mg cells or Wnt-1/C57mg
cells (data not shown). In contrast, ectopic expression of
Wnt-1 induced the expected morphological transforma-
tion of C57mg cells (data not shown). Previous reports of
ectopic expression of different Wnts in C57mg cells dem-
onstrated Wnt-1 to be highly transforming whereas Wnt-
5a failed to induce transformation [15,16]. By identifying
downstream targets of Wnt-5a and Rfz-2, we wanted to
determine which genes are responsible for these pheno-
typic changes as well as which genes might be targets of
noncanonical Wnt signaling.
RNA isolated from wt C57mg cells, C57mg cells stably
transformed by Wnt-5a and Rfz-2 retroviruses, and
C57mg cells stably transformed by Wnt-1 retrovirus were
used for DNA microarray analysis. Biotinylated cRNA
probes synthesized from the RNA were hybridized to Af-
fymetrix mouse GeneChips Mu11k subA and subB arrays.
Over 11,000 oligonucleotide probe sets were analysed in-
cluding known genes and ESTs. Two independent sets of
experiments were performed that initiated from the
growth of cells. Probe sets that underwent a 2-fold or
greater change in the Wnt-ligand expressing cells com-
pared to control cells were selected for further analysis.
Over 90 genes that repeated in both experiments appeared
to change in the Wnt-expressing cells. Of those, 50 genes
were chosen for validation by an independent method
(quantitative RT-PCR). A list of some of these genes, with
the observed fold-changes determined by DNA microar-
ray analysis and quantitative RT-PCR, is shown (Table 1;
list of primers shown in Table 2). Genes are separated by
functional categories with the greatest number of genes
having roles in cell adhesion, transcriptional regulation,BMC Developmental Biology 2003, 3 http://www.biomedcentral.com/1471-213X/3/2
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and signaling. The list of genes shows those that are spe-
cific to Wnt-5a/Rfz-2, differential between Wnt-5a/Rfz-2
and Wnt-1, specific to Wnt-1, and common to both Wnt-
1 and Wnt-5a/Rfz-2. Previously identified genes regulated
by Wnt signaling in this list include fibronectin [17], IL-6
[18], BMP-4 [19], groucho related protein [20], and Krox-
20 [21,22]. Since Wnt-5a may couple to more than one
frizzled receptor, different Wnt signaling pathways may be
activated by Wnt-5a depending on the endogenous ex-
pression of various frizzled receptors [6,10]. Thus, it is
possible that the gene expression pattern we identified
may be due to the activation of both canonical and non-
canonical Wnt signaling pathways. We compared the
Wnt-5a/Rfz-2 expression profile to the Wnt-1 expression
profile to rule out genes common in both pathways and
to identify those genes specific to Wnt-5a and Rfz-2.
We next wanted to examine whether any of these genes
were regulated in a similar manner if we used alternative
methods for expressing Wnt-1 or Wnt-5a. In particular, we
wanted to activate the function of these Wnts for short du-
rations rather than relying on stable expression. The first
approach was to co-culture C57mg cells with cells secret-
ing Wnt ligand. For the co-culture experiments, C57mg
cells were grown together with Wnt-1 or Wnt-5a express-
ing 293T cells for 24 hours. RNA was isolated and quanti-
tative RT-PCR was performed using primers to the list of
genes from Table 1. The majority of genes had little if any
background in the PCR reactions from the human 293T
cell RNA (data not shown). One gene, mesothelin, exhib-
ited a 3-fold induction in C57mg cells treated with the
Wnt-1 but not the Wnt-5a secreting 293T cells (Figure 1,
panel A). This fold change was similar to the data ob-
tained from stable expression with Wnt-1 in C57mg cells
(see Table 1). Mesothelin is a cell-surface antigen of un-
known function that is expressed in the mesothelium. It is
synthesized as a 69 kDa precursor that is proteolytically
processed into a 40 kDa membrane bound form that is
glycosylphosphatidylinositol (GPI)-linked and a 32 kDa
secreted form. The secreted form has been referred to as
megakaryocyte potentiating factor (MPF) for its ability to
stimulate the megakaryocyte colony forming activity of
murine IL-3 in mouse bone marrow cell culture [23,24].
Mesothelin expression is induced in a variety of cancers
including ovarian, pancreatic, lung, and cervical cancer
[25,26]. The soluble portion of mesothelin has drawn at-
tention as a potential serum tumor marker since it is high-
ly over-expressed in patients with ovarian carcinomas and
pancreatic adenocarcinomas [27,28].
Stromelysin-1 (SL-1) was induced almost 2-fold in
C57mg cells co-cultured with Wnt-5a secreting 293T cells
but not with Wnt-1 secreting 293T cells (Figure 1, panel
A). A similar level of induction was also observed with
Wnt-5a/293T cells co-cultured with Rfz-2/C57mg cells
(data not shown), suggesting that the induction of SL-1 is
due to expression of Wnt-5a and not only to Rfz-2. These
data are similar to the ~4 fold induction of SL-1 in Wnt-
5a/Rfz-2/C57mg cells (Table 1). SL-1 is a matrix metallo-
proteinase that can alter ECM-mediated signaling events
during development [29–31]. Both SL-1 and Wnt-5a have
Figure 1
Induction of mesothelin and SL-1 expression by Wnt-
1 or Wnt-5a signaling. A. RT-PCR was performed on 
RNA obtained from 3 separate experiments in which C57mg 
cells were co-cultured with 293T cells expressing Wnt-1, 
Wnt-5a, or CS2+ as control. The amounts of mesothelin and 
SL-1 mRNAs were normalized to HPRT and plotted as fold 
increase relative to C57mg cells co-culture with 293T cells 
expressing CS2+. B. C57mg cells (wt) or C57mg cells stably 
expressing the Rfz-2/β2AR chimeric receptor were treated 
with the β2AR agonist isoproterenol or the antagonist pro-
pranolol as control for 8 hours prior to harvesting for RNA 
extraction and RT-PCR analysis. The amounts of mesothelin 
and SL-1 mRNAs were normalized to HPRT and plotted as 
fold increase relative to propranolol treated cells. Mean lev-
els were determined from 3 separate experiments.
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roles in mammary gland development and are elevated in
certain breast cancers [32–35], although Wnt-5a is re-
duced in other types of breast cancer [36].
Since Wnt-5a may activate both vertebrate Wnt pathways
we turned to an approach that more specifically would
transiently activate the Wnt/Ca2+ signaling pathway. This
approach involves the use of a drug-inducible chimeric re-
ceptor consisting of the extracellular and transmembrane
spanning portions derived from the hamster β2 adrenergic
receptor (β2AR) and the intracellular domains derived
from Rfz-2. This receptor has previously been shown to el-
evate intracellular Ca2+ and activate CamKII in a ligand-
dependent manner [6,37,38]. C57mg cells stably trans-
formed with Rfz-2/β2AR retrovirus or wt C57mg cells were
treated overnight with propranolol, a β2AR antagonist, to
maintain the chimeric receptors in an inactivated state.
Subsequently, the β2AR agonist isoproterenol was added
Table 1: Genes differentially regulated by Wnt-5a/Rfz-2 and Wnt-1 in C57mg cells.
nd, not determined
Avg. fold changes
Functional Category of Genes GenBank acc. no. Wnt-5a Rfz-2 Wnt-1
Microarray Quant. RT-PCR Microarray Quant. RT-PCR
Cell Growth/Differentiation
BMP-4 L47480 -3 -2.4 1.4 1.2
Cell Adhesion
plasminogen activator inhibitor-1 M33960 -2.8 -2.4 2.1 1.2
osteoblast specific factor 2 D13664 -2.4 -1.6 1.4 1.1
Flt4 ligand U58112 3.3 2 1 1.2
fibronection ET62894 2 nd -1.8 nd
HTK ligand L38847 -2.1 -1.9 2.5 3.2
mesothelin D86370 -4 -2.9 8.4 2.8
stromelysin 1 X66402 3.8 4.4 -1.6 -2.5
Transcriptional Regulator
groucho-related gene 1 protein U61362 -2.1 -1.6 1.4 -1.4
retinoic acid receptor-alpha X57528 -2.3 -2 1 -1.3
Id4 helix-loop-helix protein X75018 -4.1 -3.6 1.6 -1.1
neural-restrictive silencer factor U13878 -3.5 1.1 1.6 1.8
bcl-3 M90397 1.9 2.2 -2 -1.4
Krox-20 X06746 -3.4 -1.7 6.2 1.5
Inflammation
PTX3 X83601 -2.5 -2.1 1.6 1.6
bradykinin B1 subtype receptor U47281 -2.5 4 2.7 3.2
Signaling
Rho-associated protein kinase U58513 -1.2 nd -4.9 nd
guanine nucleotide-binding protein W83658 1.6 1.7 -4.4 -4.4
signaling molecule (ATTP) U97571 -1.3 1.5 -3.5 -2.7
son of sevenless 1 Z11574 2.5 2.9 -2.6 -2
SHPS-1 D87967 -2.7 -1.4 3 -1.7
TRAF1 L35302 2.6 1.5 2 1.7
Cell surface receptor
interleukin 2 receptor gamma U21795 2 2.7 -1.4 1.9
transferrin receptor X57349 -1.6 -1.6 -2.3 -1.9
Cytokine
interleukin-6 X54542 2.1 -1.1 1.6 1
Cell Cycle
Ki-67 antigen ET62993 -1.45 -1.1 -6.5 -5.8
Axon Guidance
semaphorin F X97817 2.5 3.1 -2 -4
DM-GRASP L25274 3.3 1.8 -2.8 -2.6
Acc., accession; Avg., average; Quant., quantitative; BMP-4, bone morphogenetic protein-4; HTK ligand, hepatoma transmembrane kinase ligand; 
PTX3, pentraxin 3; SHPS-1, src homology protein substrate-1; TRAF1, TNF receptor associated factor-1. Shown is a list of genes that are differen-
tially regulated by Wnt-5a/Rfz2 and Wnt-1 in C57mg cells identified by DNA microarray analysis. The values determined by DNA microarray anal-
ysis were validated using quantitative RT-PCR. Average fold changes from DNA microarray analysis and quantitative RT-PCR were determined 
from two independent experiments and from three independent experiments performed in triplicate respectively.BMC Developmental Biology 2003, 3 http://www.biomedcentral.com/1471-213X/3/2
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Table 2: Primers used in quantitative RT-PCR.
HPRT: forward primer 5'-TGGAAAGAATGTCTTGATTGTTGAA-3'
reverse primer 5'-AGCTTGCAACCTTAACCATTTTG-3'
BMP-4: forward primer 5'-GCTTGAGTACCCGGAGCGT-3'
reverse primer 5'-TGTTCTTCGTGATGGAAACTCCT-3'
Plasminogen activator inhibitor-1: forward primer 5'-GGCCTCCAAAGACCGGA-3'
reverse primer 5'-CAGCATAGCCAGCACCGA-3'
Osteoblast specific factor 2: forward primer 5'-AAGGAAAAGGGTCATACACGTACTTC-3'
reverse primer 5'-TGCGAATGTCAGAATCCAGGT-3'
Flt4 ligand: forward primer 5'-CAGCTGCGGAAAGGCG-3'
reverse primer 5'-TTTACACTGTCCCCTGTCCTGG-3'
HTK ligand: forward primer 5'-GCAGGAGACACCGCAAACA-3'
reverse primer 5'-GTGGCCAGTGTGCTGAGAGA-3'
Mesothelin: forward primer 5'-GCAGTCAGGGAGGTTCTGAGG-3'
reverse primer 5'-GGTGGAGACTGACCACTTCGA-3'
Stromelysin-1: forward primer 5'-TGGCCATCTCTTCCATCCAA-3'
reverse primer 5'-CCCAGAACTGATTTCCTTTAAAAATG-3'
Groucho related protein 1 forward primer 5'-CCCTATGCCCCTCATTGGA-3'
reverse primer 5'-CCGTGGTTGAGGGTGTTGAT-3'
Retinoic acid receptor-alpha: forward primer 5'-AGCACCAGCTTCCAGTCAGTG-3'
reverse primer 5'-CTGCTGCTCTGGGTCTCGA-3'
Id4: forward primer 5'-GAACAAGCAGGGTGACAGCA-3'
reverse primer 5'-CCGCACACCTGGCCAT-3'
Neural-restrictive silencer factor: forward primer 5'-CGGAAGACAAATGCAGGAGTTC-3'
reverse primer 5'-TTCGGCTTCGTACTGGCAA-3'
Bcl3: forward primer 5'-GCACGGCGCCAACGT-3'
reverse primer 5'-GCCAGACGCAGAATGCAGA-3'
Krox-20: forward primer 5'-GCGGGAGATGGCATGATC-3'
reverse primer 5'-GAAGCTACTCGGATACGGGAGA-3'
PTX3: forward primer 5'-TGGACAACGAAATAGACAATGGA-3'
reverse primer 5'-CTGGCGGCAGTCGCAT-3'
Bradykinin B1 receptor: forward primer 5'-TCAACTGGCCCTTTGGAAGT-3'
reverse primer 5'-AACAGGTTGGCCTTGATGACC-3'
Guanine nucleotide-binding protein: forward primer 5'-CTGGTAGAACAGCTGAAGATGGAAG-3'
reverse primer 5'-ACAGTAGGCCATCAAGTCAGCA-3'
ATTP signaling molecule: forward primer 5'-TGCTCCACCCATTTGCTTCT-3'
reverse primer 5'-TGGCATCCACATGTTTTCCA-3'
Son of sevenless 1: forward primer 5'-CCTGAAAGCCCTCCCTTGTT-3'
reverse primer 5'-AGATGTAATGGTGAGCTTGAGAAAAC-3'
SHPS-1: forward primer 5'-GGTCAACATCTTCCACACGGTT-3'
reverse primer 5'-TTTGTGTCCTGGATCTGGGTTA-3'
TRAF1: forward primer 5'-TGTGTGGCCGGACTGTCA-3'
reverse primer 5'-AGCGCAGGCACAACTTGTAAC-3'
IL-2 receptor gamma: forward primer 5'-TTGGTGCAGTACCGGAGCA-3'
reverse primer 5'-GCAGGGAGAATCTAGGTTCATGA-3'
Transferrin receptor: forward primer 5'-GACGCTTTGGGTGCTGGT-3'
reverse primer 5'-GGCAAGTTTCAACAGAAGACCTGT-3'
IL-6: forward primer 5'-TTACACATGTTCTCTGGGAAATCG-3'
reverse primer 5'-AAGTGCATCATCGTTGTTCATACA-3'
Ki-67 antigen: forward primer 5'-TTTCAGGTCTCTGGAAGCAGTCA-3'
reverse primer 5'-ATCTCCATAATTGCTTTGATTGCA-3'
Semaphorin F: forward primer 5'-AGTGGTGAGCTCTATGCTGCAA-3'
reverse primer 5'-CCCAGACTTCGGTAAATGGC-3'
DM-GRASP: forward primer 5'-GCAAAACTGATTGTGGGAATTG-3'
reverse primer 5'-CAGTAGACGACACCAGCAACG-3'
Shown is a list of forward and reverse primers specific to the murine genes used in quantitative RT-PCR.BMC Developmental Biology 2003, 3 http://www.biomedcentral.com/1471-213X/3/2
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for 8 hours at which point RNA was isolated and quanti-
tative RT-PCR was performed. Supporting the co-culture
data discussed above, SL-1 exhibited almost a 3-fold in-
duction with isoproterenol treated Rfz-2/β2AR expressing
C57mg cells but not wt C57mg cells treated with isoprot-
erenol (Figure 1, panel B).
SL-1 appears to be up-regulated by Wnt-5a and not Wnt-1
(Table 1 and Figure 1, panel A). Conversely, mesothelin
appears to be up-regulated specifically by Wnt-1 and not
Wnt-5a since mesothelin was not induced by co-culturing
with Wnt-5a secreting cells or by activation of the chimer-
ic Rfz-2/β2AR receptor (Figure 1, panels A and B). To our
knowledge this is the first report to show that two genes
are differentially regulated by two different Wnts within
the same cell type.
In order to examine the mechanism by which Wnt-1 or
Wnt-5a regulates mesothelin or SL-1, respectively, C57mg
cells were treated with either LiCl or phorbol myristic ac-
etate (PMA). LiCl has previously been shown to mimic ac-
tivation of Wnt-1 signaling by stabilizing beta-catenin
through its inhibition of glycogen synthase kinase-3β
(GSK-3β), a kinase that phosphorylates beta-catenin and
promotes its degradation via the ubiquitin proteasome
pathway [39]. C57mg cells treated with LiCl exhibited el-
evated levels of mesothelin but not SL-1 (Figure 2, left
panel). On the other hand, PMA treatment of C57mg cells
Figure 2
Effect of Li+ or PMA on mesothelin and SL-1 expression in C57mg cells. For Li+ treatment, C57mg cells were 
treated with 10 mM LiCl or 10 mM KCl as control for 6 hours. For PMA treatment, C57mg cells were treated with 1 µM PMA 
or ethanol as control for 6 hours. RNA was extracted and RT-PCR analysis was performed using primers specific to mesothe-
lin or SL-1 mRNAs. mRNA levels were normalized to HPRT and fold increase shown is relative to KCl treatment in the case of 
Li+ and to ethanol treatment in the case of PMA. Mean levels were determined from 3 independent experiments.
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elevated SL-1 transcript levels 6-fold but not mesothelin
(Figure 2, right panel). PMA, a phorbol ester, activates
PKC and has previously been shown to activate SL-1 [40].
It appears that mesothelin is activated by Wnt-1, which
can be mimicked by LiCl, and that SL-1 is activated by
Wnt-5a in a beta-catenin-independent manner, which can
be mimicked by activating PKC.
Discussion
We used DNA microarray analysis to identify genes regu-
lated by Wnt-1 and Wnt-5a in C57mg cells. C57mg cells
were chosen since they become transformed by ectopic ex-
pression of Wnt-1 and by loss of function of Wnt-5a
[12,15,16]. In addition, Wnt-5a/Rfz-2 C57mg cells exhib-
ited phenotypic differences from wt C57mg cells (see re-
sults). We focused on two genes that showed differential
regulation by Wnt-1 and Wnt-5a since their regulation
was reproducible using several methods to activate the
Wnt signaling pathways. The first, mesothelin, was up-reg-
ulated by Wnt-1 both by stable expression of Wnt-1 in
C57mg cells and by co-culturing C57mg cells with Wnt-1
secreting cells. Similarly, mesothelin expression was in-
duced by Li+, an inhibitor of GSK-3β, that mimics Wnt-1.
Mesothelin is markedly over-expressed in a variety of can-
cers derived from tissues of the mesothelium, including
lung, cervix, and pancreas. Interestingly, mesothelin ex-
pression is induced in lung, ovarian, and pancreatic carci-
nomas where constitutive activation of Wnt signaling is
caused by stabilizing mutations in beta-catenin
[27,28,41–44]. The induction of mesothelin in these car-
cinomas may be due to misregulation of Wnt signaling as
are other targets of the Wnt pathway, c-myc and cyclin D1.
Mutations in different effectors of Wnt signaling have
been identified in a variety of cancers. Interestingly, Wnt-
5a down-regulated mesothelin expression, perhaps
through antagonism of endogenous Wnt/beta-catenin
signaling.
Second, SL-1 was up-regulated by Wnt-5a in C57mg cells.
Three lines of evidence demonstrate that SL-1 induction is
associated with activation of Wnt-5a signaling. First,
C57mg cells stably expressing Wnt-5a and Rfz-2 elevate
SL-1 levels. Second C57mg cells co-cultured with Wnt-5a
secreting cells up-regulate SL-1. Third, activation of chi-
meric Rfz-2 receptors stably expressed in C57mg cells aug-
ment SL-1 expression. To further examine how SL-1 is up-
regulated by Wnt-5a, we tested whether SL-1 induction
could be mediated by downstream effectors of Wnt/Ca2+
signaling such as PKC. Activation of PKC by PMA treat-
ment of C57mg cells did indeed elevate SL-1 levels signif-
icantly. SL-1 is an important modulator of cell adhesion
through its function as a matrix metalloproteinase that de-
grades the ECM. SL-1 induction in p2S cells, an
untransformed mouse mammary epithelial cell line, trig-
gered the disappearance of E-cadherin and beta-catenin
from cell-cell junctions and reduced the expression of
beta-catenin [35]. Wnt-5a and SL-1 may play similar roles
in inhibiting cadherin-mediated cell-adhesion, as Wnt-5a
decreases Ca2+-dependent cell adhesion similar to a dom-
inant negative cadherin [11]. The regulation of SL-1 by
Wnt-5a may be important in developmental processes
such as gastrulation where Wnt-5a affects the morphoge-
netic movement of tissues [45].
Whether mesothelin and SL-1 are direct targets of Wnt-1
and Wnt-5a, respectively, and whether alterations in their
expression are responsible for the observed phenotypic
changes in Wnt-5a/Rfz-2/C57mg cells, has yet to be deter-
mined. Whether they are direct or indirect does not alter
the observation that the expression of both change in an
unexpected manner in response to these two Wnts. Much
less is understood about Wnt-5a signaling pathway(s) and
how Wnt-5a signals are transmitted to the nucleus to af-
fect gene expression compared to the canonical Wnt/beta-
catenin signaling pathway. A recent report demonstrated
that Wnt-5a and Rfz-2 can induce the nuclear localization
of the transcription factor NF-AT [14]. Their results show
that NF-AT is a downstream target of the Wnt/Ca2+ path-
way and antagonizes the Wnt/beta-catenin pathway in
Xenopus embryos. The SL-1 promoter has putative NF-AT
binding sites but whether these are important for Wnt-5a
regulation requires further testing. Nevertheless, our data
clearly demonstrate that different Wnts have distinct ef-
fects on gene expression in a single cell line.
Conclusions
Using DNA microarray analysis we identified several
genes that are differentially regulated by Wnt-1 and Wnt-
5a signaling within the same cell type, C57mg. We
focused on two genes, mesothelin and SL-1, whose regu-
lation by Wnts was reproducible using a variety of meth-
ods to activate the Wnt signaling pathways. Mesothelin, a
potential tumor serum marker, was up-regulated by Wnt-
1 and down-regulated by Wnt-5a. SL-1, a matrix metallo-
proteinase, was up-regulated by Wnt-5a only, showing
that Wnt-5a can indeed affect gene expression. Our data
indicate that different Wnts can stimulate distinct sets of
genes.
Methods
Cell Culture, retroviral infections, and DNA transfections
C57mg cells were grown in DMEM supplemented with
10% FBS and 10 µg/ml of insulin. 293T cells were grown
in DMEM supplemented with 10% FBS. The Wnt-5a/ Rfz-
2 expressing C57mg cell line and the Rfz-2/β2AR express-
ing C57mg cell line were established by retroviral infec-
tions. The coding region for Xenopus Wnt-5a including
the myc epitope tag in pSP64T [45] was digested with
BglII, treated with klenow enzyme and ligated into the ret-
roviral vector PMI-hCD5 [46] digested with NotI andBMC Developmental Biology 2003, 3 http://www.biomedcentral.com/1471-213X/3/2
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treated with Klenow enzyme. The Rfz-2 coding sequence
from plasmid CS2+ [47] was amplified by PCR using the
following primers: 5'-AAAAGCGGCCGCGAGT-
GGGGGGCGGCGGCC-3' and 5'-AAAAGTC-
GACGCGCCCAGCAGCGAGACCGC-3'. The PCR product
was cloned into the NotI and SalI sites in PMI-hCD2 [46].
The coding sequence for the Rfz-2/β2AR chimeric receptor
in CS2+ [6,37] was digested with EcoRI and XhoI and
cloned into PMI-hCD2 at the EcoRI and SalI sites. Gener-
ation of the retrovirus, infection of the C57mg cell line,
and enrichment of infected cells was performed as de-
scribed [46,48]. Cell populations enriched to >95% were
used for RNA isolation. Total RNA was extracted using the
RNeasy Mini Kit (Qiagen) as directed by the manufactur-
er. Wnt-1 expressing C57mg cells were a kind gift from G.
Shackleford. For co-culture experiments, 293T cells were
transfected with either Xenopus Wnt-5a [45], mouse Wnt-
1 [49], or CS2+ as control using the lipofectamine PLUS
reagents (GIBCO BRL) as directed by the manufacturer. 24
hours after transfection the Wnt-expressing 293T cells
were transferred to culture dishes seeded with C57mg
cells. Both cell types were plated at a 1:1 ratio. Cells were
co-cultured for 24 hours and RNA was isolated. For induc-
tion of the Rfz-2/β2AR chimeric receptor, chimeric recep-
tor expressing C57mg cells or wt C57mg cells were treated
with 10 µM propranolol overnight and then with 10 µM
isoproterenol for 8 hours. Control cells were treated with
10 µM propranolol only. For Li+ and PMA stimulation ex-
periments, C57mg cells were incubated with 10 mM LiCl,
10 mM KCl as a control, or 1 µM PMA for 6 hours. All
treatments were followed by RNA extraction.
Oligonucleotide Array
Total RNA was extracted using the RNeasy kit (Qiagen) ac-
cording to the manufacturer's protocols. Transcript profil-
ing with Affymetrix GeneChips (Affymetrix, Santa Clara,
CA) was performed using the Mu11KsubA and subB chips
containing ~11,000 probe sets. Briefly, 15 µg of total RNA
were reverse-transcribed with an oligo(dT) primer cou-
pled to a T7 RNA polymerase binding site. Biotinylated
complementary RNA (cRNA) was then synthesized from
the resulting complementary DNA (cDNA) with the use of
T7 polymerase. 30 µg of biotinylated cRNA were then ran-
domly sheared (to an approximate length of 50 nucle-
otides). Hybridization to the arrays and first-pass analysis
of the scanned data were performed at the PAN Facility
(Stanford University, Palo Alto, California).
Reverse Transcriptase-PCR (RT-PCR) Analysis
Confirmation of gene expression was performed using
quantitative RT-PCR. cDNA was created from total RNA
using the ThermoScript RT-PCR System (Invitrogen) with
an oligo(dT)20 primer. Minus RT controls were also pre-
pared similarly. 2 µg RNA were included in each reaction
in a total volume of 20 µl. The reaction was performed at
55°C for 1 hour and terminated by incubating at 85°C for
5 minutes. The reaction was diluted 7.5-fold in water and
2.5 µl were added to the PCR reaction to yield a total vol-
ume of 25 µl. Since nonspecific amplification was ob-
tained in testing some of the primers sets with the -RT
controls, optimization of the primer concentration was
performed as per the SYBR green PCR protocol (Applied
Biosystems). Three concentrations of each of the forward
and reverse primers were used, 50 nM, 300 nM, and 900
nM, to obtain nine different combinations. The amplifica-
tion reaction was performed using the following thermo-
cycler conditions: 94°C for 5 min followed by 40 cycles of
94°C for 30 s, 60°C for 30 s, and 72°C 30 s. +RT, -RT, and
no template controls were tested for the primer concentra-
tion optimization and samples were taken out at 20, 25,
30 and 35 cycles to run on 2% agarose gels. The combina-
tion of forward and reverse primer concentrations was se-
lected based on the presence of a single band only in the
+RT sample. Using the optimized primer concentrations,
the PCR reaction was performed with the SYBR Green PCR
Master Mix (Applied Biosystems) and the ABI Prism 7700
Sequence Detector (Applied Biosystems). The amplifica-
tion reaction consisted of the following: 50°C for 2 min,
denaturation at 95°C for 10 minutes, and 40 thermal cy-
cles of 95°C for 15 s and 60°C for 1 min. PCR quantifica-
tion was performed in triplicate. Fold induction was
obtained by using the ∆∆Ct method in which all samples
are first normalized to the level of mouse hypoxanthine
phosphoribosyltransferase (HPRT) in each sample. Rela-
tive normalized units were then compared between the
experimental sample and its control. The primer sequenc-
es are shown in Table 2. To determine the specificity of the
primer sets to the murine mesothelin and SL-1 targets
genes, we performed PCR using the primers sets with
cDNA from human 293T cells, and found no
amplification.
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